Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Regenerative Medical Technology's revenue for the twelve months ending Jun 30, 2026 was $9.41M, up 94.3% year over year. For fiscal 2025 it was $5.10M, up 24.2% from the year before. The highest annual figure on record is $5.10M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.10M | +24.2% |
| FY2024 | Dec 31, 2024 | $4.11M | +70.4% |
| FY2023 | Dec 31, 2023 | $2.41M | +57.5% |
| FY2022 | Dec 31, 2022 | $1.53M | +249.5% |
| FY2021 | Dec 31, 2021 | $437.89K | +695.0% |
| FY2020 | Dec 31, 2020 | $55.08K | +83.0% |
| FY2019 | Dec 31, 2019 | $30.10K | -39.9% |
| FY2018 | Dec 31, 2018 | $50.12K | +71.4% |
| FY2017 | Dec 31, 2017 | $29.24K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.02M | +309.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.64M | +93.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.57M | +4.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.18M | +19.7% |
| Q2 FY2025 | Jun 30, 2025 | $983.32K | +23.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.36M | +67.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.51M | +145.4% |
| Q3 FY2024 | Sep 30, 2024 | $986.31K | +52.5% |
| Q2 FY2024 | Jun 30, 2024 | $793.33K | +119.5% |
| Q1 FY2024 | Mar 31, 2024 | $817.03K | +3.9% |
| Q4 FY2023 | Dec 31, 2023 | $615.57K | +8.7% |
| Q3 FY2023 | Sep 30, 2023 | $646.83K | +75.9% |
| Q2 FY2023 | Jun 30, 2023 | $361.36K | +21.5% |
| Q1 FY2023 | Mar 31, 2023 | $786.20K | +163.2% |
| Q4 FY2022 | Dec 31, 2022 | $566.26K | +124.1% |
| Q3 FY2022 | Sep 30, 2022 | $367.70K | +122.8% |
| Q2 FY2022 | Jun 30, 2022 | $297.52K | +1786.8% |
| Q1 FY2022 | Mar 31, 2022 | $298.75K | +6624.0% |
| Q4 FY2021 | Dec 31, 2021 | $252.63K | +9274.1% |
| Q3 FY2021 | Sep 30, 2021 | $165.04K | +1244.0% |
| Q2 FY2021 | Jun 30, 2021 | $15.77K | -45.2% |
| Q1 FY2021 | Mar 31, 2021 | $4.44K | -60.8% |
| Q4 FY2020 | Dec 31, 2020 | $2.70K | -43.6% |
| Q3 FY2020 | Sep 30, 2020 | $12.28K | +97.4% |
| Q2 FY2020 | Jun 30, 2020 | $28.79K | +300.5% |
| Q1 FY2020 | Mar 31, 2020 | $11.32K | -5.0% |
| Q4 FY2019 | Dec 31, 2019 | $4.78K | -59.6% |
| Q3 FY2019 | Sep 30, 2019 | $6.22K | -46.8% |
| Q2 FY2019 | Jun 30, 2019 | $7.19K | -19.3% |
| Q1 FY2019 | Mar 31, 2019 | $11.92K | -32.7% |
| Q4 FY2018 | Dec 31, 2018 | $11.82K | – |
| Q3 FY2018 | Sep 30, 2018 | $11.69K | – |
| Q2 FY2018 | Jun 30, 2018 | $8.91K | – |
| Q1 FY2018 | Mar 31, 2018 | $17.70K | – |
See a number that looks wrong?